Kelly Financial Services’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46	Closed	-$1.7K	–	225
2024 Q2	$1.7K	Hold	46	–	–	﹤0.01%	604
2024 Q1	$1.93K	Hold	46	–	–	﹤0.01%	604
2023 Q4	$1.82K	Hold	46	–	–	﹤0.01%	590
2023 Q3	$1.27K	Hold	46	–	–	﹤0.01%	596
2023 Q2	$1.56K	Hold	46	–	–	﹤0.01%	568
2023 Q1	$1.66K	Hold	46	–	–	﹤0.01%	540
2022 Q4	$2.05K	Hold	46	–	–	﹤0.01%	505
2022 Q3	$1.29K	Hold	46	–	–	﹤0.01%	549
2022 Q2	$1.24K	Hold	46	–	–	﹤0.01%	538
2022 Q1	$1.57K	Hold	46	–	–	﹤0.01%	544
2021 Q4	$1.78K	Hold	46	–	–	﹤0.01%	552
2021 Q3	$2.48K	Sell	46 -1,492	-97%	-$70K	﹤0.01%	494
2021 Q2	$46K	Buy	1,538 +1,492	+3,243%	+$41K	﹤0.01%	467
2021 Q1	$948	Hold	46	–	–	﹤0.01%	553
2020 Q4	$806	Hold	46	–	–	﹤0.01%	527
2020 Q3	$682	Hold	46	–	–	﹤0.01%	510
2020 Q2	$598	Hold	46	–	–	﹤0.01%	526
2020 Q1	$76	Hold	46	–	–	﹤0.01%	560
2019 Q4	$103	Hold	46	–	–	﹤0.01%	545
2019 Q3	$98	Hold	46	–	–	﹤0.01%	537
2019 Q2	$123	Hold	46	–	–	﹤0.01%	486
2019 Q1	$226	Buy	+46	New	+$242	﹤0.01%	464